| For: | Toita R, Kawano T, Kang JH, Murata M. Applications of human hepatitis B virus preS domain in bio- and nanotechnology. World J Gastroenterol 2015; 21(24): 7400-7411 [PMID: 26139986 DOI: 10.3748/wjg.v21.i24.7400] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i24/7400.htm |
| Number | Citing Articles |
| 1 |
Yongpeng Wang, Guy Sedar Singor Njateng, Tianrui Zhao, Meilian Yang, Yifen Wang, Jianxin Cao, Yaping Liu, Guiguang Cheng. Evaluation of Acute and Subacute Toxicity of Two Different Extracts from Que Zui Tea in Rats. eFood 2021; 2(2) doi: 10.2991/efood.k.210329.002
|
| 2 |
Huizhen Sun, Le Chang, Ying Yan, Lunan Wang. Hepatitis B virus pre‐S region: Clinical implications and applications. Reviews in Medical Virology 2021; 31(4) doi: 10.1002/rmv.2201
|
| 3 |
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Microbial Pathogenesis 2017; 109 doi: 10.1016/j.micpath.2017.04.028
|
| 4 |
Prashant Tiwari, Istuti Saraswat, Jyoti Gupta. Insight into the Biology of Hepatitis B Virus and Recent Therapeutic Approaches. Current Microbiology 2026; 83(3) doi: 10.1007/s00284-026-04725-4
|
| 5 |
Shengdi Li, Zhen Wang, Yixue Li, Guohui Ding. Adaptive evolution of proteins in hepatitis B virus during divergence of genotypes. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02012-8
|
| 6 |
Xiaodan Cai, Weihao Zheng, Shaokun Pan, Shengyuan Zhang, Youhua Xie, Haitao Guo, Guoxin Wang, Zigang Li, Ming Luo. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice. Antiviral Research 2018; 149 doi: 10.1016/j.antiviral.2017.11.007
|
| 7 |
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic. Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies. Pathogens 2024; 13(1) doi: 10.3390/pathogens13010046
|
| 8 |
Qiang Xie, Qingbo Liu, Xin Zheng, Leilei Fu, Hussein H. Aly, Bo Liu. Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies. Drug Discovery Today 2026; 31(3) doi: 10.1016/j.drudis.2026.104664
|
| 9 |
Hardik Shyam Churi, Sushma Dave. Point‐of‐Care Biosensors for Infectious Diseases. 2023; doi: 10.1002/9783527837946.ch10
|
| 10 |
J. Rajčáni, S. Szathmary. Peptide Vaccines: New Trends for Avoiding the Autoimmune Response. The Open Infectious Diseases Journal 2018; 10(1) doi: 10.2174/1874279301810010047
|
| 11 |
Jack Thomas Bell, Xiaonan Zhang. The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries. Virology 2025; 608 doi: 10.1016/j.virol.2025.110527
|
| 12 |
You-Yuan Wang, Jun-Liang Fu, Wen-Xin Wang, Hong-Min Wang, Shan-Quan Liu, Ying Sun, Zi-Wei Wang, Jing Li, Ming-Ju Zhou, Wei-Zhe Li, Meng-Meng Zhu, Xia Li, Yu-Xuan Yang, Si-Yuan Chen, Tao Yang, Xing Fan, Ruo-Nan Xu, Yan-Mei Jiao, Jin-Wen Song, Cheng Zhen, Min Zhang, Ming Shi, Fu-Sheng Wang, Chao Zhang. A preS2 aa1–26-specific humoural response marks functional cure in chronic HBV infection. eBioMedicine 2026; 129 doi: 10.1016/j.ebiom.2026.106355
|
| 13 |
Elaheh Gholami Parizad, Abbas Ali Imani Fooladi, Hamid Sedighian, Elham Behzadi, Jafar Amani, Afra Khosravi. Immune response induced by recombinant pres2/S-protein and a pres2-S-protein fused with a core 18-27 antigen fragment of hepatitis B virus compared to conventional HBV vaccine. Virus Genes 2023; 59(4) doi: 10.1007/s11262-023-01995-z
|
| 14 |
Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford. Hepatitis B vaccine nonresponders. Annals of Allergy, Asthma & Immunology 2018; 121(3) doi: 10.1016/j.anai.2018.03.017
|